<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03240263</url>
  </required_header>
  <id_info>
    <org_study_id>S60516</org_study_id>
    <nct_id>NCT03240263</nct_id>
  </id_info>
  <brief_title>Inspiratory Muscle Training in Difficult to Wean Patients</brief_title>
  <official_title>Inspiratory Muscle Training in Difficult to Wean Patients: a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Katholieke Universiteit Leuven</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Failure to wean is a clinical problem and strength training of inspiratory muscles has been
      recently proposed as possible additional component of weaning strategies. The main hypothesis
      is that inspiratory muscle training improve weaning success rates and abbreviate weaning
      duration and ICU length of stay in difficult to wean patients compared to a sham endurance
      training group.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weaning Success</measure>
    <time_frame>Maximal duration of treatment: 28 days</time_frame>
    <description>Successful separation attempt without reintubation or reconnection to the MV</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Difficult to Wean Patients</condition>
  <arm_group>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High intensity inspiratory muscle training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham endurance training</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham inspiratory muscle training at low intensity</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Inspiratory Muscle Training</intervention_name>
    <description>Supervised daily sessions of training including 4 sets of 6-10 breaths using a tapared flow resistive load device*. Resistance adjusted to the highest tolerable load.
*Electronic Variable Flow Resistive Loading IMT Device/ POWERbreathe®KH1, HaB International Ltd., Southam, UK</description>
    <arm_group_label>Inspiratory muscle training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endurance training</intervention_name>
    <description>Supervised daily sessions of training including 4 sets of 6-10 breaths using a tapared flow resistive load device*. Low training resistance adjusted to &lt;10% maximal inspiratory pressure.
*Electronic Variable Flow Resistive Loading IMT Device/ POWERbreathe®KH1, HaB International Ltd., Southam, UK</description>
    <arm_group_label>Sham endurance training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Difficult and prolonged weaning patients

          -  Adequate oxygenation

          -  Febrile temperature &lt; 38ºC

          -  Hemodynamic stability

          -  Stable blood pressure

          -  No or minimal pressors

          -  No myocardial ischemia

          -  Adequate hemoglobin and mentation

          -  Resolution of disease acute phase

          -  Able to follow simple verbal commands related to IMT

          -  Mechanically ventilated via a tracheostomy or endotracheal tube

        Exclusion Criteria:

          -  Pre-existing neuromuscular disease

          -  Agitation

          -  Hemodynamically instable (arrhythmia, decompensated heart failure, coronary
             insufficiency)

          -  Hemoptysis

          -  Diaphoresis

          -  Spinal cord injury above T8

          -  Use of any type of home MV support prior to hospitalization

          -  Skeletal pathology that impairs chest wall movements

          -  Poor general prognosis or fatal outcome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rik Gosselink, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel Langer, PT, PhD</last_name>
    <phone>032-16-330192</phone>
    <email>daniel.langer@faber.kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzleuven.be/ec</url>
    <description>Institutional Review Board</description>
  </link>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2017</study_first_submitted>
  <study_first_submitted_qc>August 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 7, 2017</study_first_posted>
  <last_update_submitted>August 2, 2017</last_update_submitted>
  <last_update_submitted_qc>August 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Katholieke Universiteit Leuven</investigator_affiliation>
    <investigator_full_name>Daniel Langer</investigator_full_name>
    <investigator_title>PT, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

